Literature DB >> 8814919

Slow nocturnal home hemodialysis at the Wellesley Hospital.

R Uldall1, M Ouwendyk, R Francoeur, L Wallace, W Sit, S Vas, A Pierratos.   

Abstract

To alleviate the overcrowding of in-center hemodialysis (HD) facilities, we have developed slow nocturnal home hemodialysis (SNHHD), an innovative form of renal replacement therapy. SNHHD is performed 5 to 7 nights/week for 8 hours, during sleep, with a blood flow of 300 mL/min and a dialysate flow of 100 mL/min. The vascular access is by means of the Uldall-Cook catheter, which allows for easy patient access with low infection rates. Special precautions were taken to prevent accidental disconnection during sleep. Dialysis functions were monitored via a modem from the patient's home to the SNHHD center and have proven valuable in increasing patient confidence. The removal of urea, phosphate, and B2 microglobulin (B2M) during 1 week of SNHHD greatly exceeds that of thrice weekly conventional HD. Five patients have completed training and have been successfully performing SNHHD for 6 to 16 months. All patients have discontinued phosphate binders and increased dietary phosphate intake. Four out of five patients report sleeping soundly and experience greatly increased energy and stamina. Repeated in situ reuse of the dialyzer and the blood lines will reduce the patients work and make SNHHD a very inexpensive modality.

Entities:  

Mesh:

Year:  1996        PMID: 8814919     DOI: 10.1016/s1073-4449(96)80053-7

Source DB:  PubMed          Journal:  Adv Ren Replace Ther        ISSN: 1073-4449


  7 in total

Review 1.  There's no place like home: 35-year patient survival on home hemodialysis.

Authors:  Jerry Z Yu; Connie M Rhee; Antoney Ferrey; Alex Li; Anna Jin; Yongen Chang; Uttam Reddy; Wei Ling Lau; Jason Chou; Jula Inrig; Kamyar Kalantar-Zadeh
Journal:  Semin Dial       Date:  2017-12-18       Impact factor: 3.455

2.  Frequent hemodialysis: history of the modality and assessment of outcomes.

Authors:  Douglas M Silverstein
Journal:  Pediatr Nephrol       Date:  2017-04-11       Impact factor: 3.714

3.  Ten years experience of in-center thrice weekly long overnight hemodialysis.

Authors:  Joanna Ruth Powell; Oyeniran Oluwaseun; Yook Mun Woo; Neal Padmanabhan; Eliyanachii Narasinghan; Carol Latta; Julie Tortolano; Alan G Jardine; Colin C Geddes
Journal:  Clin J Am Soc Nephrol       Date:  2009-05-21       Impact factor: 8.237

4.  Patient-perceived barriers to the adoption of nocturnal home hemodialysis.

Authors:  Joseph A Cafazzo; Kevin Leonard; Anthony C Easty; Peter G Rossos; Christopher T Chan
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-01       Impact factor: 8.237

5.  Achievements and challenges in bioartificial kidney development.

Authors:  Farah Tasnim; Rensheng Deng; Min Hu; Sean Liour; Yao Li; Ming Ni; Jackie Y Ying; Daniele Zink
Journal:  Fibrogenesis Tissue Repair       Date:  2010-08-10

6.  International practice patterns and factors associated with non-conventional hemodialysis utilization.

Authors:  Nathan Allen; Daniel Schwartz; Paul Komenda; Robert P Pauly; Deborah Zimmerman; Gemini Tanna; Jeffery Schiff; Claudio Rigatto; Manish M Sood
Journal:  BMC Nephrol       Date:  2011-12-05       Impact factor: 2.388

7.  Control of hyperphosphatemia and maintenance of calcemia in CKD.

Authors:  Aluizio Barbosa Carvalho; Fabiana Baggio Nerbass; Lilian Cuppari
Journal:  J Bras Nefrol       Date:  2021-12-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.